Forum key takeaways:
Summary:
The 2013 Healthcare Meetings Forum steering committee emphasized ongoing dialogue among stakeholders, focusing on event quality over quantity, viewing compliance positively, and adapting promotional strategies. They raised questions about the roles of different event sizes, managing compliance, communicating sponsorship value, balancing multi-channel support, and defining compliance responsibilities.
Key Takeaway Points:
- Ongoing Dialogue: Continuous conversation among stakeholders is essential beyond the forum.
- Quality over Quantity: Focus on high-quality, targeted events rather than the number of events and attendees.
- Positive Compliance: Compliance drives productive directions in healthcare meetings.
- Evolving Promotion: Pharma needs to measure returns in terms of engagement with prescribing influencers, not just commercial impact.
- Scientific Education: A common focus on scientific education benefits both medical and commercial interests.
- Event Roles: Further exploration needed on the roles of large congresses, mid-size, and smaller targeted events.
- Compliance Management: Corporate sponsors must address all compliance aspects, not just logistics.
- Sponsorship Value: Communicating the value of corporate sponsorship to senior management is critical.
- Multi-Channel Balance: The right balance of multi-channel and social media support for healthcare meetings needs to be defined.
- Compliance Responsibility: Determining where compliance responsibility lies—pharma, agencies, venues, or healthcare providers—requires further discussion.
Please note the view in this report reflect the views and content available at the time. In some cases the conclusions have been realised or changed in the time since their creation.
